Annual revenue:
$58.49M+$14.61M(+33.30%)Summary
- As of today (June 20, 2025), RXRX annual revenue is $58.49 million, with the most recent change of +$14.61 million (+33.30%) on December 31, 2024.
- During the last 3 years, RXRX annual revenue has risen by +$48.49 million (+484.88%).
- RXRX annual revenue is now at all-time high.
Performance
RXRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$14.82M+$10.31M(+228.49%)Summary
- As of today (June 20, 2025), RXRX quarterly revenue is $14.82 million, with the most recent change of +$10.31 million (+228.49%) on March 31, 2025.
- Over the past year, RXRX quarterly revenue has increased by +$1.33 million (+9.84%).
- RXRX quarterly revenue is now -43.19% below its all-time high of $26.08 million, reached on September 30, 2024.
Performance
RXRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$59.81M+$1.33M(+2.27%)Summary
- As of today (June 20, 2025), RXRX TTM revenue is $59.81 million, with the most recent change of +$1.33 million (+2.27%) on March 31, 2025.
- Over the past year, RXRX TTM revenue has increased by +$14.58 million (+32.24%).
- RXRX TTM revenue is now -7.41% below its all-time high of $64.60 million, reached on September 30, 2024.
Performance
RXRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RXRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.3% | +9.8% | +32.2% |
| 3 y3 years | +484.9% | +179.6% | +367.3% |
| 5 y5 years | +3318.3% | - | - |
RXRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +484.9% | -43.2% | +228.5% | -7.4% | +367.3% |
| 5 y | 5-year | at high | +3318.3% | -43.2% | +1619.0% | -7.4% | +6839.1% |
| alltime | all time | at high | +3318.3% | -43.2% | +1619.0% | -7.4% | +6839.1% |
RXRX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $14.82M(+228.5%) | $59.81M(+2.3%) |
| Dec 2024 | $58.49M(+33.3%) | $4.51M(-82.7%) | $58.49M(-9.5%) |
| Sep 2024 | - | $26.08M(+81.1%) | $64.60M(+32.9%) |
| Jun 2024 | - | $14.40M(+6.8%) | $48.62M(+7.5%) |
| Mar 2024 | - | $13.49M(+27.0%) | $45.23M(+3.1%) |
| Dec 2023 | $43.88M(+10.6%) | $10.62M(+5.2%) | $43.88M(-6.5%) |
| Sep 2023 | - | $10.10M(-8.3%) | $46.93M(-5.9%) |
| Jun 2023 | - | $11.02M(-9.2%) | $49.88M(+7.2%) |
| Mar 2023 | - | $12.13M(-11.3%) | $46.52M(+17.2%) |
| Dec 2022 | $39.68M | $13.68M(+4.8%) | $39.68M(+39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $13.05M(+70.6%) | $28.50M(+58.8%) |
| Jun 2022 | - | $7.65M(+44.4%) | $17.95M(+40.3%) |
| Mar 2022 | - | $5.30M(+112.0%) | $12.80M(+28.0%) |
| Dec 2021 | $10.00M(+193.0%) | $2.50M(0.0%) | $10.00M(-0.5%) |
| Sep 2021 | - | $2.50M(0.0%) | $10.05M(+19.5%) |
| Jun 2021 | - | $2.50M(0.0%) | $8.41M(+42.3%) |
| Mar 2021 | - | $2.50M(-2.0%) | $5.91M(+73.2%) |
| Dec 2020 | $3.41M(+99.5%) | - | - |
| Dec 2020 | - | $2.55M(+195.9%) | $3.41M(+295.9%) |
| Sep 2020 | - | $862.00K | $862.00K |
| Dec 2019 | $1.71M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual revenue year-on-year change?
- What is Recursion Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly revenue year-on-year change?
- What is Recursion Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM revenue year-on-year change?
What is Recursion Pharmaceuticals annual revenue?
The current annual revenue of RXRX is $58.49M
What is the all time high annual revenue for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual revenue is $58.49M
What is Recursion Pharmaceuticals annual revenue year-on-year change?
Over the past year, RXRX annual revenue has changed by +$14.61M (+33.30%)
What is Recursion Pharmaceuticals quarterly revenue?
The current quarterly revenue of RXRX is $14.82M
What is the all time high quarterly revenue for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly revenue is $26.08M
What is Recursion Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, RXRX quarterly revenue has changed by +$1.33M (+9.84%)
What is Recursion Pharmaceuticals TTM revenue?
The current TTM revenue of RXRX is $59.81M
What is the all time high TTM revenue for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM revenue is $64.60M
What is Recursion Pharmaceuticals TTM revenue year-on-year change?
Over the past year, RXRX TTM revenue has changed by +$14.58M (+32.24%)